1. Home
  2. Uncategorized
  3. Nov. 3: “Ablative Radiotherapy in Oligometastatic Cancer” grand rounds
Uncategorized

Nov. 3: “Ablative Radiotherapy in Oligometastatic Cancer” grand rounds

Aaron Grossberg, MD, PhD, an assistant professor of radiation medicine at OHSU, presents

Share:

Asante providers and medical staff are invited to attend the Asante Oncology Grand Rounds lecture, “Ablative Radiotherapy in Oligometastatic Cancer.” Aaron Grossberg, MD, PhD, an assistant professor of radiation medicine at Oregon Health & Science University, presents.

This hour-long CME event takes place at noon on Thursday, Nov. 3, in the first-floor conference room at the Mary and Dick Heimann Cancer Center, 3011 E. Barnett Road in Medford.

Dr. Grossberg earned his medical and doctorate degrees at OHSU before completing his residency training in radiation oncology at MD Anderson Cancer Center at the University of Texas.

His practice focuses on cancers of the pancreas and breast. He specializes in the use of stereotactic body radiation therapy (SBRT) and hypofractionated radiation for treatment of both early and locally advanced pancreas cancer with an emphasis on genetic and molecular factors that affect toxicities after radiation therapy.

In a joint appointment with the Cancer Early Detection Advanced Research Center and the Brenden-Colson Center for Pancreatic Care, Dr. Grossberg studies the interaction between cancer and metabolism in an effort to identify ways to diagnose cancers sooner and improve the quality of life of cancer patients.

These grand rounds are made possible with the support of the Asante Foundation’s Skyrman Educational Fund.

Aaron Grossberg, MD

Location (click to enlarge map)

Heimann map
Tags: , , , ,
Employee flu clinics now under way
Best practice alert: Preventing spread of Stenotrophomonas

If you need answers for a personal work matter, please contact the author or department directly instead of leaving a comment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

COVID 19 Bug

Categories

Popular related content